Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS46000241BKPyvENSG00000105486.15protein_codingLIG1NoNo3978F5GZ28
P18858
TVIS30010618HIVENSG00000105486.15protein_codingLIG1NoNo3978F5GZ28
P18858
TVIS30048978HIVENSG00000105486.15protein_codingLIG1NoNo3978F5GZ28
P18858
TVIS30048979HIVENSG00000105486.15protein_codingLIG1NoNo3978F5GZ28
P18858
TVIS30048980HIVENSG00000105486.15protein_codingLIG1NoNo3978F5GZ28
P18858
TVIS30048981HIVENSG00000105486.15protein_codingLIG1NoNo3978F5GZ28
P18858
TVIS30048982HIVENSG00000105486.15protein_codingLIG1NoNo3978F5GZ28
P18858
TVIS30048983HIVENSG00000105486.15protein_codingLIG1NoNo3978F5GZ28
P18858
TVIS30048984HIVENSG00000105486.15protein_codingLIG1NoNo3978F5GZ28
P18858
TVIS30048985HIVENSG00000105486.15protein_codingLIG1NoNo3978F5GZ28
P18858
TCGA Plot Options
Drug Information
GeneLIG1
DrugBank IDDB01280
Drug NameNelarabine
Target IDBE0000199
UniProt IDP18858
Regulation Typeinhibitor
PubMed IDs18035189; 18473971
CitationsBuie LW, Epstein SS, Lindley CM: Nelarabine: a novel purine antimetabolite antineoplastic agent. Clin Ther. 2007 Sep;29(9):1887-99.@@Curbo S, Karlsson A: Nelarabine: a new purine analog in the treatment of hematologic malignancies. Rev Recent Clin Trials. 2006 Sep;1(3):185-92.
GroupsApproved; Investigational
Direct ClassificationPurine nucleosides
SMILESCOC1=NC(N)=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O
Pathways
PharmGKBPA164752425
ChEMBLCHEMBL1201112